Form 8-K TENET HEALTHCARE CORP For: Oct 29

Go back to Form 8-K TENET HEALTHCARE CORP For: Oct 29

Wolfe Research Reiterates Outperform Rating on Tenet Healthcare (THC)

October 29, 2024 10:08 AM EDT

Wolfe Research analyst Justin Lake reiterated an Outperform rating and $178.00 price target on Tenet Healthcare (NYSE: THC).

The analyst comments "THC 3Q24 Beat on Strong SS Volume / Revenue Growth in Hospitals - THC reported 3Q24 rev of $5.12B, up 1.2% y/y ~1% above expectations. Adj. EBITDA of $978M up... More